Chinese vaccines bringing life in Latin America back to normal

Hopes for economic recovery rise as region contains COVID-19 pandemic

The Rio de Janeiro Carnival is one of the world's best-known events, with colorful floats and dancers in flamboyant costumes attracting hundreds of thousands of revelers to the boisterous Brazilian street festival.

After being canceled last year due to the COVID-19 pandemic, the 10-day annual celebration made a glitzy comeback in April, symbolizing a return to normalcy for Brazil and many other Latin American countries.

According to observers, Chinese vaccines have played a large part in containing the pandemic in Brazil by helping to curb new infections and improving public health.

"The return of the Rio Carnival was very important," said Henrique de Moura Reis, international relations manager at the China Trade Center Group, which works to promote trade, technological and cultural cooperation between China and Brazil.

"Many people in Brazil view the event as a party, but it goes far beyond that. It is important, as it helps promote a large chain of services and businesses. Many workers in Brazil depend on the Carnival.

"The public watched the parades from bleachers－it was no different to a soccer stadium full of fans, and there was no negative impact from the virus afterward."

On May 22, Brazil officially ended its two-year health emergency, which was put in place at the onset of the pandemic.

Ending such emergencies has not been easy for Brazil and neighboring nations, many of which are starting to treat the virus as endemic, meaning that it is essentially a permanent feature of life, rather than a pandemic emergency.

Widespread inoculations made it possible to end the emergency in Brazil, with Chinese vaccines, either supplied directly or manufactured in the South American nation, playing a significant role in combating COVID-19.

Announcing the end of the emergency, Brazil's Minister of Health Marcelo Queiroga said, "As a result of vaccination, Brazil has witnessed a plunge of over 80 percent in the moving average of case numbers and deaths from COVID-19 since the peak reached during the Omicron variant earlier this year."

The Brazilian government announced it was ending the health emergency immediately after the successful return of the Rio Carnival, lifting people's spirits and raising hopes for an economic revival after two years of grim news and lockdowns.

The Carnival generates more than 250,000 seasonal jobs and has many other related economic and social benefits.

Benny Spiewak, a lawyer and partner at SPLaw, which specializes in the life sciences sector in Brazil, said: "I believe we have reached this stage mostly because of the vaccines. I understand the value of lockdowns, quarantine and face masks, but ultimately, two, three or four jabs are what got us here."

CoronaVac, manufactured by Chinese biopharmaceutical company Sinovac Biotech, was the first COVID-19 vaccine to be approved under emergency conditions by Anvisa, the Brazilian healthcare regulatory agency.

Spiewak said: "Monitoring the approval process was as exciting as watching a soccer game. We watched it live on television. It was a science-driven response, and it was incredible to see this amazing medical miracle."

The "medical miracle" worked in Brazil largely thanks to a technology transfer agreement between Sinovac Biotech and the Butantan Institute in Sao Paulo, through which the Chinese vaccines are completed and packaged.

Efforts continuing

Queiroga, the health minister, said healthcare providers in Brazil have administered 750 million doses of COVID-19 vaccines.

"Most of the Brazilian population has had all the doses, and we are moving forward with boosters," he said.

Despite this progress, vaccination efforts are continuing and are proving vital for Latin American countries to get back on track after two years.

Carissa F. Etienne, director of the Pan American Health Organization, said at a recent media briefing: "Over two-thirds of people in Latin America and the Caribbean have now received two doses of COVID-19 vaccine. These vaccines work and are very safe … they are protecting most people in our region from the worst consequences of COVID-19 infection."

In Colombia, which has a population of about 50 million, more than 38 million people have been vaccinated against COVID-19, with CoronaVac a cornerstone of the country's strategy to combat the virus.

Jeronimo Marulanda, an independent entrepreneur and consultant in Bogota, the Colombian capital, said: "Colombia is an example of vaccine management in the region. With a combined strategy of vaccination and controlled spread of the SARS-CoV-2 virus, the country has managed, in large part, to control the pandemic."

Marulanda's parents, who are over 70 years old, and his 6-year-old son received CoronaVac jabs last year.

"My son had a mild COVID-19 infection after completing his jabs, but thanks to Sinovac's vaccine, his symptoms were like those experienced with mild flu," he said.

In Colombia, where more than 16.6 million CoronaVac inoculations have been administered, the vaccine was the first to be approved for 5- to 12-year-olds.

"People in many areas of the country have been inoculated with the Sinovac vaccine, and results on the ground show that it works," Marulanda said.

Sinovac Biotech, which is committed to continuing to help the region, has announced investment of $100 million to build a vaccine plant in Bogota.

Meng Weining, Sinovac vice-president, said: "Many countries have faced a major challenge in vaccine supply during the pandemic. Having a local production facility will enable the region to supply vaccines when needed in the future to protect the population."

Sinovac Biotech is building a similar plant in Santiago, the Chilean capital, to produce vaccines for COVID-19, flu and hepatitis A.The vaccines will be packaged at the plant for distribution across the region.

Yin Weidong, the company's CEO, has said, "Sinovac will engage in investment and scientific research in Chile … to improve production that will allow more people in South America to have access to vaccines."

Vaccines have enabled much of the region to return to some kind of normality, even though COVID-19 cases are rising again in some countries, including Argentina, where the Minister of Health Carla Vizzotti said, "As much as we would like it to be, the pandemic is not over."